drugset / Trial / NCT07495969
Randomized Clinical Trial of Endovascular Recanalization for Symptomatic Non-Acute Intracranial Artery Occlusion（REPAIR）
RandomizedParallel-groupSingle-blindTreatment
Summary
A multicenter, randomized, open-label, endpoint-blinded trial to compare the effects of endovascular recanalization plus aggressive medical management with aggressive medical management alone on stroke recurrence and mortality in patients with symptomatic non-acute intracranial artery occlusion.
Timeline
- Start
- 2026-04-01
- Primary completion
- 2027-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Aspirin | Small molecule | 100 mg | — |
| Background | Cilostazol | Small molecule | — | — |
| Background | Clopidogrel | Small molecule | 75 mg | — |
| Background | Ticagrelor | Small molecule | — | — |